DAUNOXOME Safety Questions, DAUNOXOME Answers
More Here>>Side Effects - FDA Reports 2006-2008
Medications A-Z: A B C D E F G H I J K L M N O P Q R S T U V W X Y ZWelcome! Patientsville.com provides unique information about DAUNOXOME. Our extensive database of DAUNOXOME adverse events and DAUNOXOME warnings is updated regularly. If you have questions, you can post them to one of our health experts or ask others in our broad patient community.
>> Announcements
Check out our Hospital and Home Care Quality Reports.
Ask Our Health Experts about DAUNOXOME
DAUNOXOME Safety Reports
Total DAUNOXOME reports: 5.DAUNOXOME FDA safety alerts: No.
Reported deaths: 2 Reported hospitalizations: 4.
Take DAUNOXOME Side Effects Survey or Share Your DAUNOXOME Story. DAUNOXOME Usage.
Health Professional from FRANCE reported DAUNOXOME problem on Dec 20, 2006. Female patient, 26 years of age, weighting 125.7 lb, was treated with DAUNOXOME. After drug was administered, patient experienced the following problems/side effects: cardiac failure, hepatitis, renal failure acute, respiratory distress, shock. DAUNOXOME dosage: unknown. During the same period patient was treated with ARACYTINE. Patient died.
DAUNOXOME problem was reported by a Health Professional from FRANCE on Jan 11, 2007. Male patient, 43 years of age, weighting 143.3 lb, was diagnosed with kaposi's sarcoma, herpes virus infection, pyrexia, hiv infection and was treated with DAUNOXOME. After drug was administered, patient experienced the following problems/side effects: blood alkaline phosphatase increased, gamma-glutamyltransferase increased. DAUNOXOME dosage: unknown. During the same period patient was treated with NEUPOGEN, ZELITREX, PERFALGAN, EPIVIR, NORVIR. Patient was hospitalized. Patient recovered.
Health Professional from FRANCE reported DAUNOXOME problem on Mar 01, 2007. Male patient, 43 years of age, weighting 143.3 lb, was diagnosed with kaposi's sarcoma, hiv infection and was treated with DAUNOXOME. After drug was administered, patient experienced the following problems/side effects: blood alkaline phosphatase increased, gamma-glutamyltransferase increased, herpes simplex, pyrexia. DAUNOXOME dosage: unknown. During the same period patient was treated with NEUPOGEN, EPIVIR, NORVIR. Patient was hospitalized. Patient recovered.
DAUNOXOME problem was reported by a Health Professional from UNITED STATES on Mar 23, 2007. Female patient, weighting 169.8 lb, was diagnosed with acute lymphocytic leukaemia and was treated with DAUNOXOME. After drug was administered, patient experienced the following problems/side effects: pneumonia. DAUNOXOME dosage: unknown. During the same period patient was treated with ELSPAR, METHOTREXATE, PREDNISONE, VINCRISTINE SULPHATE. Patient was hospitalized. Patient recovered.
Consumer or non-health professional from FRANCE reported DAUNOXOME problem on Aug 23, 2006. Female patient, weighting 22.05 lb, was diagnosed with acute leukaemia, acute myeloid leukaemia, nausea, vomiting, tumour lysis syndrome, agranulocytosis, antibiotic prophylaxis and was treated with DAUNOXOME. After drug was administered, patient experienced the following problems/side effects: accidental overdose, aplasia, cardiac arrest, chills, pain, prostration, respiratory distress, vomiting. DAUNOXOME dosage: unknown. During the same period patient was treated with ARACYTINE, ZOPHREN, FASTURTEC, FLUDARABINE, GRANOCYTE, PLITICAN, BACTRIM. Patient was hospitalized. Patient died on 07/18/2006.